DeepCure
Reimagining small molecule therapies for immune diseases
Boston, United States · $64.6M raised
- Headquarters
- Boston, Massachusetts
- Business Model
- B2B
- Website
- deepcure.com
- Total Funding
- $64.6M
- Last Round
- $24.6M Series AApr 2024
- Rounds
- 2
About
DeepCure's proprietary PocketExpander technology uses AI and physics-based methods, including quantum mechanical and molecular dynamics simulations, to identify physical and chemical features on protein surfaces that can interact with small molecules — enabling it to pursue targets with no known ligand and design molecular glues. Its MolGen molecular generation tool uses deep reinforcement learning to build readily synthesizable compound libraries meeting ADME-Tox and target candidate profile requirements. DiscoveryHub, its collaboration platform, lets structural biologists, computational chemists, AI engineers, medicinal chemists and biologists share data across the design-make-test-analyze cycle.
Summary
DeepCure is an Artificial Intelligence company based in Boston, United States. It has raised $64.6M in total across 2 rounds, most recently a $24.6M Series A round in Apr 2024.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.

xAI is an AI platform for accelerating human scientific discovery.

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...